StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $443.48MP/E –Yield –

Vireo Growth total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Vireo Growth's total debt was $58.21M at Mar 31, 2023. For fiscal 2022 it was $58.03M, up 112.3% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$58.03M+112.3%
FY2021Dec 31, 2021$27.33M+2362.2%
FY2020Dec 31, 2020$1.11M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2023Mar 31, 2023$58.21M+86.5%
Q4 FY2022Dec 31, 2022$58.03M+112.3%
Q3 FY2022Sep 30, 2022$55.63M+171.1%
Q2 FY2022Jun 30, 2022$45.85M+133.4%
Q1 FY2022Mar 31, 2022$31.21M+66.4%
Q4 FY2021Dec 31, 2021$27.33M+2362.2%
Q3 FY2021Sep 30, 2021$20.52M–
Q2 FY2021Jun 30, 2021$19.64M–
Q1 FY2021Mar 31, 2021$18.76M–
Q4 FY2020Dec 31, 2020$1.11M–

More Vireo Growth figures

See a number that looks wrong?